» Articles » PMID: 16018876

Candidates for Tumor-specific Alternative Splicing

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2005 Jul 16
PMID 16018876
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Gene expression can be regulated not only by transcription and post-transcriptional modifications, but also by splicing regulation. Recent genome-wide analyses have indicated that up to 70% of human genes may have alternatively spliced forms, suggesting that splicing regulation affects a wide range of gene expression. Tumor tissues show significantly altered protein expressions, and this is also thought to be affected by alternative splicing. Although some alternative splicing events have been reported to be cancer specific and others have been predicted from database analyses, the process of alternative splicing and its regulatory machinery are hardly understood. We searched for and detected alternative splicing events that alter protein splicing in all or a subset of tumor tissues. The results revealed tissue-specific alterations of splicing regulation by tumorigenesis, and regulatory cis-element analyses further suggested that multiple splicing regulatory machineries were affected by this process.

Citing Articles

Mammary gland selective excision of c-jun identifies its role in mRNA splicing.

Katiyar S, Jiao X, Addya S, Ertel A, Covarrubias Y, Rose V Cancer Res. 2011; 72(4):1023-34.

PMID: 22174367 PMC: 3288968. DOI: 10.1158/0008-5472.CAN-11-3647.


Exon array analysis using re-defined probe sets results in reliable identification of alternatively spliced genes in non-small cell lung cancer.

Langer W, Sohler F, Leder G, Beckmann G, Seidel H, Grone J BMC Genomics. 2010; 11:676.

PMID: 21118496 PMC: 3053589. DOI: 10.1186/1471-2164-11-676.


Alternative splicing and tumor progression.

Ghigna C, Valacca C, Biamonti G Curr Genomics. 2009; 9(8):556-70.

PMID: 19516963 PMC: 2694562. DOI: 10.2174/138920208786847971.


Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array.

Gardina P, Clark T, Shimada B, Staples M, Yang Q, Veitch J BMC Genomics. 2006; 7:325.

PMID: 17192196 PMC: 1769375. DOI: 10.1186/1471-2164-7-325.


Molecular models for the tissue specificity of DNA mismatch repair-deficient carcinogenesis.

Chao E, Lipkin S Nucleic Acids Res. 2006; 34(3):840-52.

PMID: 16464822 PMC: 1361617. DOI: 10.1093/nar/gkj489.